Danielle Hughey
Family · Woodstock, GANPI 1205255148
Payments from drug & device makers
Across 235 payments — averaging $16.83 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$2K
- Novo Nordisk$606
- Lilly USA, LLC$546
- Pfizer$170
- Baxter Healthcare$120
- AstraZeneca$114
- plus $866 from 15 others
What the payments were for
- Food & beverage$3,955100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 84 | $1,532 |
| Novo Nordisk | 57 | $606 |
| Lilly USA, LLC | 32 | $546 |
| Pfizer | 9 | $170 |
| Baxter Healthcare | 1 | $120 |
| AstraZeneca | 7 | $114 |
| Takeda Pharmaceuticals U.S.A., Inc. | 5 | $111 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 5 | $103 |
| IBSA Pharma Inc. | 3 | $76 |
| Biohaven Pharmaceuticals, Inc. | 3 | $72 |
| Exact Sciences | 4 | $70 |
| Eisai Inc. | 5 | $70 |
| Biohaven Pharmaceutical Holding Company Ltd. | 3 | $65 |
| Daiichi Sankyo Inc. | 3 | $60 |
| GSK | 3 | $53 |
| Amgen | 3 | $53 |
| Astellas Pharma US Inc | 2 | $40 |
| Merck | 2 | $37 |
| Esperion Therapeutics, Inc. | 1 | $26 |
| Linus Health, Inc. | 1 | $16 |
| Genentech USA, Inc. | 2 | $14 |
How this compares
$3,955 in reported general payments places this provider in the 90th percentile of 6,258 family providers in Georgia.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| MounjaroTirzepatide | 27 | $35,097 |
| OzempicSemaglutide | 13 | $21,976 |
| EdarbiAzilsartan Medoxomil | 12 | $3,044 |
| Estradiol (Twice Weekly)Estradiol | 35 | $2,274 |
| Liothyronine Sodium | 35 | $1,810 |
| ProgesteroneProgesterone, Micronized | 29 | $845 |
| Levothyroxine Sodium | 87 | $844 |
| Estradiol (Once Weekly)Estradiol | 14 | $396 |
| Atorvastatin Calcium | 23 | $309 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 13 | $224 |
| Sertraline Hcl | 24 | $168 |
| Rosuvastatin Calcium | 12 | $138 |
| Gabapentin | 15 | $136 |
| Fluconazole | 17 | $117 |
| Losartan Potassium | 21 | $85 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Lilly USA, LLCMounjaro | $546 | $35,09727 claims |
| Novo NordiskOzempic | $606 | $21,97613 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 6,258 family providers in Georgia.
Other family in Woodstock
- Allie McAllisterMarietta$299K
- Tonita WashingtonLawrenceville$153K
- Erin HenryLawrenceville$135K
- Trisha RomanPeachtree City$134K
- Lori ReedMarietta$106K
- Julia BranchCumming$102K
- Hannah BanachWaycross$85K
- Morgan GroothandEvans$81K
- Anna Carolina WrightLilburn$69K
- Jessica FeehanCanton$51K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.